Source: Annual Congress 2010 - News from RCT (randomised controlled trials) and epidemiology in sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
R. Tamisier, D. Lacedonia, D. Monneret, J. P. Baguet, P. Levy, J. L. Pepin (La Tronche, Grenoble Cedex 09, France). Effects of CPAP and valsartan randomly assigned on baroreflex function and aldosterone in hypertensive OSAS. Eur Respir J 2010; 36: Suppl. 54, 1663

Member's Comments

No comment yet.

Related content which might interest you: Impact of CPAP treatment on sympathetic activity and renin-angiotensin-aldosterone system in normotensive men with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 294s Year: 2006 Comparison of continuous positive airway pressure and valsartan 160 mg in hypertensive sleep apnoea patients never treated for both conditions: the VALSAS study Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Long term effects of CPAP in blood pressure in nonsleepy hypertensive OSA patients Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 No reduction of blood pressure with CPAP in non-sleepy hypertensive OSA patients Source: ISSN=ISSN 1810-6838, ISBN=, page=193 Year: 2006 CPAP vs APAP effects on metabolic and cardiac function in patients with OSAS Source: Eur Respir J 2005; 26: Suppl. 49, 722s Year: 2005 Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Effects of autoCPAP treatment for obstructive sleep apnea on 24-hour blood pressure and nocturnal catecholamines Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients Source: Eur Respir J 2004; 23: 255-262 Year: 2004 CPAP and measures of cardiovascular risk in males with OSAS Source: Eur Respir J 2008; 32: 1488-1496 Year: 2008 Ventilatory dysregulation and sleep apnea occurence in non-obese high-fat fed rats: effect of metformin treatment Source: Eur Respir J 2004; 24: Suppl. 48, 333s Year: 2004 Vagal and sympathetic component of arterial baroreflex are altered after 14 nights of intermittent hypoxia in healthy subjects Source: Annual Congress 2008 - Pathogenesis of obstructive sleep apnoea Year: 2008 Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP Source: Eur Respir J 2007; 30: 496-500 Year: 2007 Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007 Glucose metabolism markers in non-diabetic OSAS patients. Effect of compliance to CPAP treatment Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007 Comparative effects of amlodipine and sildenafil on the NT-proBNP levels of patients with COPD-induced pulmonary hypertension Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Effect of continuous positive airway pressure on 24 h ambulatory blood pressure in hypertensive patients with OSA Source: Eur Respir J 2007; 30: Suppl. 51, 333s Year: 2007 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans Source: Eur Respir J 2011; 37: 119-128 Year: 2011 Role of plasmatic leptin in response to hypercapnia in obese patients with or without OSAS Source: Annual Congress 2007 - Pathogenesis of obstructive sleep apnoea Year: 2007 CPAP versus CPAP plus low dose of PDE-inhibitor in men with obstructive sleep apnea-hypopnea syndrome (OSAHS) and erectile dysfunction (ED) Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010